Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)
Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits) is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-07-06. On CanQuery you can follow the original downloads. Files are available in English and French.
On December 13, 2017, Health Canada published the Regulations Amending the Food and Drug Regulations (DIN Requirements for Drugs in Dosage Form Listed in Schedule C to the Food and Drugs Act) in Canada Gazette, Part II. The objective of this regulatory amendment is to apply to Schedule C Drugs (radiopharmaceuticals and kits), the requirement to have a Drug Identification Number (DIN) in order for a drug to be sold in Canada. Along with the new requirement for all Schedule C drugs to have a DIN, the labelling requirements have also been updated to reflect the new requirement: instead of requiring the Establishment Licence number to be on the label, there will now be a requirement for the DIN to be on the label.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-06
Data overview
- Formats
- HTML
- File languages
- English, French